Valuation : Alcon

Market Cap 34.04B 29.27B 27.54B 25.13B 46.89B 3,227B 47.14B 326B 126B 1,650B 128B 125B 5,249B P/E 2026 *
39.6x
P/E 2027 * 25.1x
Enterprise Value 36.59B 31.46B 29.59B 27.01B 50.4B 3,468B 50.66B 351B 136B 1,773B 137B 134B 5,642B EV / Sales 2026 *
3.3x
EV / Sales 2027 * 3.01x
Free-Float
97.34%
Yield 2026 *
0.53%
Yield 2027 * 0.59%
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
+18.66%0.00% - - 34.04B
+0.71%-6.24%-42.90%-13.70% 79.39B
-2.00%-4.25%-11.68%-24.16% 34.04B
-2.07%-2.02%-1.32%-22.43% 13.57B
+1.13%+5.03% - - 12.65B
+2.57%-1.92%-4.73%+625.95% 2.64B
+0.64%-0.36%-38.44%-57.43% 1.46B
+2.45%+8.90% - - 968M
-0.92%-5.88%+16.41%+1.48% 924M
-0.88%-1.84%-36.50%-20.69% 887M
Average +0.22%-1.27%-17.02%+69.86% 16.28B
Weighted average by Cap. +0.01%-4.56%-29.40%-4.97%

Financials

2026 *2027 *
Net sales 11.09B 9.53B 8.97B 8.19B 15.28B 1,051B 15.36B 106B 41.12B 537B 41.64B 40.73B 1,710B 11.77B 10.12B 9.52B 8.69B 16.22B 1,116B 16.3B 113B 43.66B 571B 44.21B 43.25B 1,815B
Net income 764M 657M 618M 564M 1.05B 72.45B 1.06B 7.32B 2.83B 37.03B 2.87B 2.81B 118B 1.26B 1.08B 1.02B 929M 1.73B 119B 1.74B 12.07B 4.67B 61B 4.73B 4.62B 194B
Net Debt 2.54B 2.19B 2.06B 1.88B 3.51B 241B 3.52B 24.39B 9.44B 123B 9.56B 9.35B 392B 1.45B 1.25B 1.17B 1.07B 2B 137B 2.01B 13.9B 5.38B 70.26B 5.44B 5.33B 224B
Logo Alcon
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!